Location: Home
  • search
  • go
  • Relate News
  • 1/17/2022China NMPA Novel Drug Approvals 2021 (PharmCube)
  • 1/17/2022Licensing Moves Towards Early-Stage Assets in 2021: PharmaDJ
  • 1/17/2022Massive Series A Rounds in December 2021 Highlight New R&D Trends: Pha...
  • 1/14/2022Recent Executive Moves
  • 1/14/2022NMPA Announces Package Insert Revision of Cimetidine Injectable Formul...
  • 1/13/2022FUJIFILM Irvine Scientific Plans Bioprocessing Center in China
  • 1/11/2022Reuters: Biotech Is Set for a Geopolitical Stress Test
  • 1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...
  • 1/11/2022China Solidifies Drug-Buying Programme That Saved $55 Billion
  • 1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ
  • 1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...
  • 1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...
  • 1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China
  • 1/7/2022Recent Executive Moves
  • 1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...
  • 1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...
  • 1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca
  • 1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...
  • 1/5/2022Review of Sino-Foreign Drug Out-licensing Deals in 2021
  • 1/5/2022Review of Chinese Pharma In-licensing Deals in 2021
  • 1/5/2022SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...
  • 1/5/2022China 2021: The NRDL Readout (PharmExec)
  • 1/4/2022Santhera Enters into Exclusive License Agreement with Sperogenix for V...
  • 1/3/2022Daewoong Submits BTX Product Nabota in China
  • 1/3/2022Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed
  • 1/3/2022Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...
  • 12/30/2021Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...
  • 12/30/2021Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...
  • 12/30/2021NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...
  • 12/30/2021NMPA Issues the 14th Five Year Plan for National Drug Safety and Promo...
  • Page:77/360 Total number of articles:10791: [First][<<] [75] [76] [77] [78] [79] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group